Veröffentlichungen

Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination

S.V. Fazal
J.A. Gomez-Sanchez
L.J. Wagstaff
N. Musner
G. Otto
M. Janz
R. Mirsky
K.R. Jessen

01. August 2017 in Ann Oncol

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies

U.P. Rohr
P. Herrmann
K. Ilm
H. Zhang
S. Lohmann
A. Reiser
A. Muranyi
J. Smith
S. Burock
M. Osterland
K. Leith
S. Singh
P. Brunhoeber
R. Bowermaster
J. Tie
M. Christie
H.L. Wong
P. Waring
K. Shanmugam
P. Gibbs
U. Stein

Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012)

N. Baras
S. Dahm
J. Haberland
M. Janz
K. Emrich
K. Kraywinkel
A. Salama

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

K.D. Wurster
F. Hummel
J. Richter
M. Giefing
S. Hartmann
M.L. Hansmann
S. Kreher
K. Köchert
D. Krappmann
W. Klapper
M. Hummel
S.S. Wenzel
G. Lenz
M. Janz
B. Dörken
R. Siebert
S. Mathas

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

I. Sturm
C. Stephan
B. Gillissen
R. Siebert
M. Janz
S. Radetzki
K. Jung
S. Loening
B. Doerken
P.T. Daniel

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

M. Janz
M. Hummel
M. Truss
B. Wollert-Wulf
S. Mathas
K. Joehrens
C. Hagemeier
K. Bommert
H. Stein
B. Doerken
R.C. Bargou

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

S. Mathas
M. Janz
F. Hummel
M. Hummel
B. Wollert-Wulf
S. Lusatis
I. Anagnostopoulos
A. Lietz
M. Sigvardsson
F. Jundt
K. Joehrens
K. Bommert
H. Stein
B. Doerken